Dargent D
Hôpital Edouard Herriot, Lyon, France.
Curr Opin Obstet Gynecol. 1993 Jun;5(3):294-300.
Laparoscopic surgery undoubtedly has a role in the management of gynecologic cancer. As a matter of fact, the current strategy in all fields of oncology is to select high-risk and low-risk patients. The reasoning behind such a strategy is essentially to avoid for the latter the hazards of heavy treatment and to lessen the cost-to-benefit ratio. With this in mind, the laparoscopic pelvic lymphadenectomy, which is the emblematic procedure in the field of oncologic laparoscopic surgery, appears to be very useful, but only in cases where an actual risk of lymph node involvement does exist and where it may be followed in patients with negative nodes by a less aggressive treatment. Gynecologic oncologists are the only ones who can at the same time make a diagnosis, decide which treatment may be done in the patients with negative nodes, and perform the needed operation. The disasters seen in relation to ovarian cysts demonstrate the danger that does exist if we allow oncologic laparoscopic surgery to fall into inexperienced hands.
腹腔镜手术无疑在妇科癌症的治疗中发挥着作用。事实上,肿瘤学各个领域目前的策略是筛选出高风险和低风险患者。这种策略背后的基本原理是,对于低风险患者,避免过度治疗带来的危害,并降低成本效益比。考虑到这一点,腹腔镜盆腔淋巴结清扫术作为肿瘤腹腔镜手术领域的标志性手术,似乎非常有用,但前提是确实存在淋巴结受累的实际风险,并且对于淋巴结阴性的患者,后续可以采用侵入性较小的治疗方法。妇科肿瘤学家是唯一能够同时进行诊断、决定对淋巴结阴性患者采取何种治疗方法并实施所需手术的人。与卵巢囊肿相关的不良后果表明,如果让缺乏经验的人进行肿瘤腹腔镜手术,确实存在危险。